Research ArticleClinical Studies
A Phase I/II Study of NAC with Docetaxel, Cisplatin, and S-1 for Stage III Gastric Cancer
YUSAKU TANAKA, CHIKARA KUNISAKI, YUSUKE IZUMISAWA, HIROCHIKA MAKINO, JUN KIMURA, SHO SATO, HIROSHI MIYAMOTO, TAKASHI KOSAKA, HIDETAKA A. ONO, MASAZUMI TAKAHASHI, KEI SATO, HIROTOSHI AKIYAMA and ITARU ENDO
Anticancer Research October 2018, 38 (10) 6015-6021; DOI: https://doi.org/10.21873/anticanres.12951
YUSAKU TANAKA
1Department of Surgery, Gastroenterological Center, Yokohama City University, Yokohama, Japan
CHIKARA KUNISAKI
1Department of Surgery, Gastroenterological Center, Yokohama City University, Yokohama, Japan
YUSUKE IZUMISAWA
1Department of Surgery, Gastroenterological Center, Yokohama City University, Yokohama, Japan
HIROCHIKA MAKINO
1Department of Surgery, Gastroenterological Center, Yokohama City University, Yokohama, Japan
JUN KIMURA
1Department of Surgery, Gastroenterological Center, Yokohama City University, Yokohama, Japan
SHO SATO
1Department of Surgery, Gastroenterological Center, Yokohama City University, Yokohama, Japan
HIROSHI MIYAMOTO
1Department of Surgery, Gastroenterological Center, Yokohama City University, Yokohama, Japan
TAKASHI KOSAKA
1Department of Surgery, Gastroenterological Center, Yokohama City University, Yokohama, Japan
HIDETAKA A. ONO
1Department of Surgery, Gastroenterological Center, Yokohama City University, Yokohama, Japan
MASAZUMI TAKAHASHI
2Department of Surgery, Yokohama Municipal Hospital, Yokohama, Japan
KEI SATO
3Department of Gastroenterological Surgery, Graduate School of Medicine, Yokohama City University, Yokohama, Japan
HIROTOSHI AKIYAMA
3Department of Gastroenterological Surgery, Graduate School of Medicine, Yokohama City University, Yokohama, Japan
ITARU ENDO
3Department of Gastroenterological Surgery, Graduate School of Medicine, Yokohama City University, Yokohama, Japan
In this issue
Anticancer Research
Vol. 38, Issue 10
October 2018
A Phase I/II Study of NAC with Docetaxel, Cisplatin, and S-1 for Stage III Gastric Cancer
YUSAKU TANAKA, CHIKARA KUNISAKI, YUSUKE IZUMISAWA, HIROCHIKA MAKINO, JUN KIMURA, SHO SATO, HIROSHI MIYAMOTO, TAKASHI KOSAKA, HIDETAKA A. ONO, MASAZUMI TAKAHASHI, KEI SATO, HIROTOSHI AKIYAMA, ITARU ENDO
Anticancer Research Oct 2018, 38 (10) 6015-6021; DOI: 10.21873/anticanres.12951
A Phase I/II Study of NAC with Docetaxel, Cisplatin, and S-1 for Stage III Gastric Cancer
YUSAKU TANAKA, CHIKARA KUNISAKI, YUSUKE IZUMISAWA, HIROCHIKA MAKINO, JUN KIMURA, SHO SATO, HIROSHI MIYAMOTO, TAKASHI KOSAKA, HIDETAKA A. ONO, MASAZUMI TAKAHASHI, KEI SATO, HIROTOSHI AKIYAMA, ITARU ENDO
Anticancer Research Oct 2018, 38 (10) 6015-6021; DOI: 10.21873/anticanres.12951
Jump to section
Related Articles
- No related articles found.
Cited By...
- Safety and Efficacy of Neoadjuvant Chemotherapy for Advanced Gastric Cancer in Elderly Patients
- Adjuvant Chemotherapy With S-1 Plus Docetaxel Versus S-1 Plus Oxaliplatin in Stage III Gastric Cancer
- Long-term Outcomes of Neoadjuvant Chemotherapy With Docetaxel, Cisplatin and S-1 for Stage III Gastric Cancer